Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Pfizer vaccine 90% effective against Covid... and wall street is happy.
#41
Quote: @Vanguard83 said:
yeah, I know.  It’s just my cynicism.

I think of all the commercials I watch for the drugs available to help with depression....

”....people taking XYZ, may experience difficulty breathing, or irregular chest pains, and in some patients has been found to cause renal failure. certain blood cancers have been linked to XYZ, contact your doctor if you are experiencing dizzness, loss of breath, or extreme fatigue”

....great.....

If I was depressed BEFORE taking XYZ, Im sure finding out my liver is shutting down, or have been diagnosed with lymphoma will really help my depression.
I don't think they should be able to advertise medications on television or anywhere else. That seems highly unethical to me. The list of side effects on some of those medications is scary as hell. There is a lot of advertisements for blood pressure and diabetes medications too, of course with the amount of obesity in the United States that makes sense. They are using medication advertisements for target markets. It's quite repulsive.
Reply

#42
How Ticketmaster Plans to Check Your Vaccine Status for Concerts: Exclusive
Monday's news that pharmaceutical company Pfizer's early results on a new COVID-19 vaccine showed a 90% efficacy rate on an initial clinical trial have given concert professionals hope that the business can start mounting a return in 2021. As part of that preparation, Ticketmaster has been working on a framework for post-pandemic fan safety that uses smart phones to verify fans' vaccination status or whether they've tested negative for the coronavirus within a 24 to 72 hour window.

Many details of the plan, which is still in development phase, will rely on three separate components -- the Ticketmaster digital ticket app, third party health information companies like CLEAR Health Pass or IBM's Digital Health Pass and testing and vaccine distribution providers like Labcorp and the CVS Minute Clinic.
Here's how it would work, if approved: After purchasing a ticket for a concert, fans would need to verify that they have already been vaccinated (which would provide approximately one year of COVID-19 protection) or test negative for coronavirus approximately 24 to 72 hours prior to the concert. The length of coverage a test would provide would be governed by regional health authorities -- if attendees of a Friday night concert had to be tested 48 hours in advance, most could start the testing process the day before the event. If it was a 24-hour window,  most people would likely be tested the same day of the event at a lab or a health clinic.
Once the test was complete, the fan would instruct the lab to deliver the results to their health pass company, like CLEAR or IBM. If the tests were negative, or the fan was vaccinated, the health pass company would verify the attendee's COVID-19 status to Ticketmaster, which would then issue the fan the credentials needed to access the event. If a fan tested positive or didn't take a test to verify their status, they would not be granted access to the event. There are still many details to work out, but the goal of the program is for fans to take care of vaccines and testing prior to the concert and not show up hoping to be tested onsite.
Ticketmaster would not store or have access to fans' medical records and would only receive verification of whether a fan is cleared to attend an event on a given date. Different states will have different requirements. The main role of companies like health pass companies will be to collect data from testing and medical providers and deliver status updates to partner companies in a secure, encrypted way that complies with the Health Insurance Portability and Accountability Act (HIPAA).
To date, the Food and Drug Administration has not approved any third-party companies to provide the complex technology needed to deliver real-time vaccination results, but Ticketmaster president Mark Yovich expects the demand for digital screening services -- which will be needed for airline travel, employment verification and theme park entry -- will attract a new wave of investors and entrepreneurs to fuel the growth of a new COVID-19 technology sector.
"We’re already seeing many third-party health care providers prepare to handle the vetting -- whether that is getting a vaccine, taking a test, or other methods of review and approval - which could then be linked via a digital ticket so everyone entering the event is verified," Yovich tells Billboard. "Ticketmaster’s goal is to provide enough flexibility and options that venues and fans have multiple paths to return to events, and is working to create integrations to our API and leading digital ticketing technology as we will look to tap into the top solutions based on what’s green-lit by officials and desired by clients."
For Ticketmaster, two new technologies at the companies will help its clients scale the program. The first is digital ticketing that's linked to a fan’s identity, eliminates paper tickets and can be restricted from being transferred or resold. Ticketmaster also plans to deploy its new SmartEvent system, which helps event organizers and fans manage social distancing, delayed entry and provide possible opportunities for contact tracing. Many of the safety parameters will be set by regional health officials and event organizers. Event organizers also have the ability to set their own prevention protocols, like sanitation, mask compliance and social distancing.
Because Ticketmaster tickets the vast majority of sports leagues in the United States, as well as concert venues and Live Nation owned properties, the implementation of their COVID-19 plan will be an important milestone for the live entertainment industry.
“In order for live events to return, technology and science are going to play huge roles in establishing integrated protocols so that fans, artists, and employees feel safe returning to venues," says Marianne Herman, co-founder and principal reBUILD20, which focuses on helping entertainment and live events companies develop COVID-19 strategies. "Integrating ticketing platforms with the guests verified testing results is one key way to reimagine how we’re going to get fans back to live events. The experience of attending live events will look completely different, but innovation married with consistent implementation will provide a framework to get the live sports and event industry back to work.
”https://www.billboard.com/articles/business/touring/9481166/ticketmaster-vaccine-check-concerts-plan
Reply

#43
Quote: @StickyBun said:
@purplefaithful said:
90% effective? That's right up there with measles, mumps and rubella.

Folks, the bodies are being stored in freezer trucks again in El Paso and we could double the deaths to 400k by New Year. 

Anyone still believing this is just a flu? Is beyond any help. 
LOL, oh PF....SO many dumbshits think this is NOTHING TO WORRY ABOUT. You aren't going to change any minds until someone they love or are close to dies of it and they see how it goes down. Empathy took a train out of town 4 years ago. These numbnuts distrust vaccines now. Science doesn't exist to these people, only faith-based nonsense.

Covid is the silent, clean killer...People die in the crushing isolation and silence of the ICU. There is no film of them dying cause they cant breathe or their organs shut-down. 

They aren't melting into puddles in living rooms or the streets, their eyeballs aren't falling out, they're not vomiting blood and guts all over nor are limbs falling off.

If this was a ghastly killer? The narrative may be different, the fear much higher. 

It's also happening "to others" --- for now...

You're right, #'s don't mean much. Fatality rates vs influenza don't matter and the fact that health care workers, teachers putting their lives @ risk everyday is taken for granted by many. 


Reply

#44
Glen Deshields, a Pfizer coronavirus vaccine volunteer in Texas, said the side effects of the shot were more severe than he expected, but he urged Americans to get the vaccine "as soon as you can." Deshields, appearing on "Fox & Friends," said after the first of the two-shot treatment he had a headache, fatigue and pain on the injection site for three or four days. The second shot produced similar issues but not as severe, he said.
This week Pfizer reported that its vaccine has been found to be 90% effective against COVID-19, with more than 43,000 people being tested around the world. Deshields tweeted that his grandfather once told him "one of his first memories was of bells ringing to mark the end of WWI. If true, this is that kind of moment. I am honored to be a part of this trial."
Fauci: Pandemic won't be around 'a lot longer'The nation's preeminent infectious disease expert says the pandemic won't be around "a lot longer" but probably won't be eradicated either. Dr. Anthony Fauci, speaking at a virtual health conference Thursday, said public health officials might need to "maintain control chronically" over COVID-19.
"It may be something that becomes endemic that we have to just be careful about," Fauci said.  "Certainly it's not going to be a pandemic for a lot longer because I believe the vaccines are going to turn that around."
U.S. pharmaceutical giant Pfizer and its collaborator BioNTech released early study results Monday indicating that their vaccine candidate prevented more than 90% of infections with the virus that causes COVID-19. If all goes well, FDA approval could come as soon as next month, but mass distribution of any vaccines remains months away.
https://www.usatoday.com/story/news/heal...255240002/
Reply

#45
Moderna expects to know by the end of the month whether its Covid-19 vaccine works

(CNN) — Moderna has finished accumulating data for a first analysis of its Covid-19 vaccine and expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday.
Pfizer announced Monday that its coronavirus vaccine is more than 90% effective.
Moderna is conducting a clinical trial of 30,000 participants, with half receiving the vaccine and half receiving a placebo, which is a shot of saline that does nothing.
In order for Moderna's vaccine to be considered for authorization by the US Food and Drug Administration, at least 53 study participants needed to become ill with Covid-19.
The trial hit that 53 mark Wednesday, but Moderna doesn't know if the participants who became ill received the vaccine or the placebo. The company is now preparing data to send to the trial's Data and Safety Monitoring Board, an independent panel of experts.
That board will look to see how many of the participants who became ill received the vaccine and how many received the placebo. If a statistically significant number received the placebo, that means the vaccine is effective against the virus.
Moderna thinks the board will share efficacy results before the end of the month. And, since cases are rapidly rising in the US, more than 53 participants will become ill with Covid-19 by the time the announcement is made.

Pfizer's vaccine is good news for Moderna
Moderna and Pfizer use messenger RNA for their vaccines. Dr. Anthony Fauci has said Pfizer's promising outcomes are good news for Moderna, too.
"Moderna has an almost identical mRNA," Fauci told Financial Times correspondent Hannah Kuchler in an interview posted Wednesday. "We hope we're going to see a similar kind of result from Moderna. If we do, then we'll have two vaccines in play."
Pfizer's results from the never-before-approved mRNA technology were better than expected, said Fauci, director of the National Institute of Allergy and Infectious Diseases.
Get CNN Health's weekly newsletter 
"I really quite honestly did not expect that we would have a result as striking as this -- more than 90%, close to 95% efficacy -- on the first vaccine that went through the gate," he said.
Moderna is working with NIAID to develop its vaccine.
"I would really be surprised if we did not see a high degree of efficacy," Fauci said. "You know it may not be 95%, it might be 90 or 96 or 89, but it's going to be up there. I'm fairly certain it's going to be up there."
https://www.cnn.com/2020/11/11/health/moderna-vaccine-november-results/index.html

Reply

#46
Quote: @purplefaithful said:
Moderna expects to know by the end of the month whether its Covid-19 vaccine works

(CNN) — Moderna has finished accumulating data for a first analysis of its Covid-19 vaccine and expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday.
Pfizer announced Monday that its coronavirus vaccine is more than 90% effective.
Moderna is conducting a clinical trial of 30,000 participants, with half receiving the vaccine and half receiving a placebo, which is a shot of saline that does nothing.
In order for Moderna's vaccine to be considered for authorization by the US Food and Drug Administration, at least 53 study participants needed to become ill with Covid-19.
The trial hit that 53 mark Wednesday, but Moderna doesn't know if the participants who became ill received the vaccine or the placebo. The company is now preparing data to send to the trial's Data and Safety Monitoring Board, an independent panel of experts.
That board will look to see how many of the participants who became ill received the vaccine and how many received the placebo. If a statistically significant number received the placebo, that means the vaccine is effective against the virus.
Moderna thinks the board will share efficacy results before the end of the month. And, since cases are rapidly rising in the US, more than 53 participants will become ill with Covid-19 by the time the announcement is made.

Pfizer's vaccine is good news for Moderna
Moderna and Pfizer use messenger RNA for their vaccines. Dr. Anthony Fauci has said Pfizer's promising outcomes are good news for Moderna, too.
"Moderna has an almost identical mRNA," Fauci told Financial Times correspondent Hannah Kuchler in an interview posted Wednesday. "We hope we're going to see a similar kind of result from Moderna. If we do, then we'll have two vaccines in play."
Pfizer's results from the never-before-approved mRNA technology were better than expected, said Fauci, director of the National Institute of Allergy and Infectious Diseases.
Get CNN Health's weekly newsletter 
"I really quite honestly did not expect that we would have a result as striking as this -- more than 90%, close to 95% efficacy -- on the first vaccine that went through the gate," he said.
Moderna is working with NIAID to develop its vaccine.
"I would really be surprised if we did not see a high degree of efficacy," Fauci said. "You know it may not be 95%, it might be 90 or 96 or 89, but it's going to be up there. I'm fairly certain it's going to be up there."
https://www.cnn.com/2020/11/11/health/moderna-vaccine-november-results/index.html

These studies with results based on high efficacy drugs are slower to validate, data sets with lots of zero's, you have to wait till enough people get sick to prove its a valid sample.
Reply

#47
Quote: @BigAl99 said:
@purplefaithful said:
Moderna expects to know by the end of the month whether its Covid-19 vaccine works

(CNN) — Moderna has finished accumulating data for a first analysis of its Covid-19 vaccine and expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday.
Pfizer announced Monday that its coronavirus vaccine is more than 90% effective.
Moderna is conducting a clinical trial of 30,000 participants, with half receiving the vaccine and half receiving a placebo, which is a shot of saline that does nothing.
In order for Moderna's vaccine to be considered for authorization by the US Food and Drug Administration, at least 53 study participants needed to become ill with Covid-19.
The trial hit that 53 mark Wednesday, but Moderna doesn't know if the participants who became ill received the vaccine or the placebo. The company is now preparing data to send to the trial's Data and Safety Monitoring Board, an independent panel of experts.
That board will look to see how many of the participants who became ill received the vaccine and how many received the placebo. If a statistically significant number received the placebo, that means the vaccine is effective against the virus.
Moderna thinks the board will share efficacy results before the end of the month. And, since cases are rapidly rising in the US, more than 53 participants will become ill with Covid-19 by the time the announcement is made.

Pfizer's vaccine is good news for Moderna
Moderna and Pfizer use messenger RNA for their vaccines. Dr. Anthony Fauci has said Pfizer's promising outcomes are good news for Moderna, too.
"Moderna has an almost identical mRNA," Fauci told Financial Times correspondent Hannah Kuchler in an interview posted Wednesday. "We hope we're going to see a similar kind of result from Moderna. If we do, then we'll have two vaccines in play."
Pfizer's results from the never-before-approved mRNA technology were better than expected, said Fauci, director of the National Institute of Allergy and Infectious Diseases.
Get CNN Health's weekly newsletter 
"I really quite honestly did not expect that we would have a result as striking as this -- more than 90%, close to 95% efficacy -- on the first vaccine that went through the gate," he said.
Moderna is working with NIAID to develop its vaccine.
"I would really be surprised if we did not see a high degree of efficacy," Fauci said. "You know it may not be 95%, it might be 90 or 96 or 89, but it's going to be up there. I'm fairly certain it's going to be up there."
https://www.cnn.com/2020/11/11/health/moderna-vaccine-november-results/index.html

These studies with results based on high efficacy drugs are slower to validate, data sets with lots of zero's, you have to wait till enough people get sick to prove its a valid sample.
That makes perfect sense...With the winter spike as bad as it's getting? They may not have to wait as long as you think. Not a good thing btw, right?


Reply

#48
Good for science, not for those about to be sick or dead.
Reply

#49
Quote: @StickyBun said:
@purplefaithful said:
90% effective? That's right up there with measles, mumps and rubella.

Folks, the bodies are being stored in freezer trucks again in El Paso and we could double the deaths to 400k by New Year. 

Anyone still believing this is just a flu? Is beyond any help. 
LOL, oh PF....SO many dumbshits think this is NOTHING TO WORRY ABOUT. You aren't going to change any minds until someone they love or are close to dies of it and they see how it goes down. Empathy took a train out of town 4 years ago. These numbnuts distrust vaccines now. Science doesn't exist to these people, only faith-based nonsense.

Lost two friends to this bullshit, a mentor and the other a mother.  One 68, the other 34.   Both died alone in a hospital room.
Had a funeral service via zoom. 

This is the culling of the stupid in this country, 200,000 new cases per day coming, let it happen.
Just let it happen
Reply

#50
Quote: @Skodin said:
@StickyBun said:
@purplefaithful said:
90% effective? That's right up there with measles, mumps and rubella.

Folks, the bodies are being stored in freezer trucks again in El Paso and we could double the deaths to 400k by New Year. 

Anyone still believing this is just a flu? Is beyond any help. 
LOL, oh PF....SO many dumbshits think this is NOTHING TO WORRY ABOUT. You aren't going to change any minds until someone they love or are close to dies of it and they see how it goes down. Empathy took a train out of town 4 years ago. These numbnuts distrust vaccines now. Science doesn't exist to these people, only faith-based nonsense.

Lost two friends to this bullshit, a mentor and the other a mother.  One 68, the other 34.   Both died alone in a hospital room.
Had a funeral service via zoom.  
Very sorry to hear, that sucks.You have my condolences.

It's a real s hit show just about everywhere now, not just the Midwest, not just the elderly and not just the cities and suburbs. Rural MN is even getting hit hard. 

We had our own personal scare recently...Wife and I were exposed, then tested negative 6 days later. We're both at a more vulnerable age group.

Couldn't go back to work for 2 weeks even with the negative test. Lost a good chunk of November sales income unfortunately, but did get some Covid pay along the way. 

Ours was a 1st world problem and I readily admit that. The Pandemic sucks. 


Reply



Forum Jump:


Users browsing this thread:
2 Guest(s)

Powered By MyBB, © 2002-2024 Melroy van den Berg.